- Home
- EXEL vs NVVEW Comparison
EXEL vs NVVEW Comparison
Compare EXEL & NVVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EXEL | NVVEW |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | China |
| Employees | N/A | 12 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | N/A |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EXEL | NVVEW |
|---|---|---|
| Price | $42.52 | $0.02 |
| Analyst Decision | Buy | |
| Analyst Count | 24 | 0 |
| Target Price | ★ $45.18 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | N/A |
| Earning Date | 11-04-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.55 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $2,288,218,000.00 | N/A |
| Revenue This Year | $9.84 | N/A |
| Revenue Next Year | $11.92 | N/A |
| P/E Ratio | $17.67 | ★ N/A |
| Revenue Growth | ★ 9.93 | N/A |
| 52 Week Low | $31.90 | N/A |
| 52 Week High | $49.62 | N/A |
Technical Indicators
Market Signals| Indicator | EXEL | NVVEW |
|---|---|---|
| Relative Strength Index (RSI) | 54.09 | 46.93 |
| Support Level | $40.83 | $0.01 |
| Resistance Level | $42.09 | $0.02 |
| Average True Range (ATR) | 1.09 | 0.00 |
| MACD | -0.22 | -0.00 |
| Stochastic Oscillator | 47.70 | 55.70 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About NVVEW Nuvve Holding Corp. Warrant
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.